Mobia Medical, Inc. (NASDAQ:MOBI) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have earned a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $20.75.

MOBI has been the topic of several recent research reports. Zacks Research upgraded Mobia Medical to a “hold” rating in a report on Wednesday, June 3rd. Wall Street Zen upgraded shares of Mobia Medical from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. Wolfe Research started coverage on Mobia Medical in a research report on Tuesday, June 2nd. They issued an “outperform” rating on the stock. Weiss Ratings initiated coverage on Mobia Medical in a research note on Wednesday, August 12th. They set a “sell (e-)” rating for the company. Finally, JPMorgan Chase & Co. lifted their target price on Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th.

Insider Buying and Selling at Mobia Medical

In other Mobia Medical news, Director Casey Tansey acquired 35,572 shares of the stock in a transaction dated Thursday, August 13th. The stock was purchased at an average cost of $11.51 per share, for a total transaction of $409,433.72. Following the acquisition, the director owned 268,904 shares in the company, valued at $3,095,085.04. The trade was a 15.25% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Over the last 90 days, insiders bought 87,000 shares of company stock worth $1,016,367.

Institutional Trading of Mobia Medical

An institutional investor recently bought a new position in Mobia Medical stock. Citadel Advisors LLC bought a new position in shares of Mobia Medical, Inc. (NASDAQ:MOBI) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 50,000 shares of the company’s stock, valued at approximately $670,000. Citadel Advisors LLC owned 0.15% of Mobia Medical as of its most recent filing with the Securities and Exchange Commission.

Mobia Medical Stock Down 0.6%

Shares of MOBI opened at $10.71 on Thursday. The stock has a 50-day moving average price of $11.42. The firm has a market cap of $356.54 million and a PE ratio of -0.53. Mobia Medical has a 12-month low of $9.85 and a 12-month high of $15.29. The company has a current ratio of 13.28, a quick ratio of 12.80 and a debt-to-equity ratio of 0.04.

Mobia Medical (NASDAQ:MOBI) last announced its earnings results on Tuesday, August 11th. The company reported ($1.10) EPS for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The business had revenue of $13.51 million during the quarter. The company’s revenue for the quarter was up 102.4% compared to the same quarter last year. On average, equities research analysts expect that Mobia Medical will post -2.63 EPS for the current year.

About Mobia Medical

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.